We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
- Authors
Hiroshi Arima; Cheetham, Timothy; Christ-Crain, Mirjam; Cooper, Deborah; Gurnell, Mark; Drummond, Juliana B.; Levy, Miles; McCormack, Ann I.; Verbalis, Joseph; Newell-Price, John; Wass, John A. H.
- Abstract
'What's in a name? That which we call a rose/By any other name would smell as sweet.' (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare's implication is that a name is nothing but a word and it therefore represents a convention with no intrinsic meaning. Whilst this may be relevant to romantic literature, disease names do have real meanings, and consequences, in medicine. Hence, there must be a very good rationale for changing the name of a disease that has a centuries-old historical context. A working group of representatives from national and international endocrinology, nephrology and pediatric societies now proposes changing the name of 'diabetes insipidus' to 'arginine vasopressin deficiency (AVP-D)' for central etiologies and 'argi nine vasopressin resistance (AVP-R)' for nephrogenic etiologies. This editorial provides both the historical context and the rationale for this proposed name change.
- Subjects
SHAKESPEARE, William, 1564-1616; DIABETES insipidus; VASOPRESSIN; DISEASE nomenclature; PEDIATRIC nephrology
- Publication
European Journal of Endocrinology, 2022, Vol 187, Issue 5, pP1
- ISSN
0804-4643
- Publication type
Article
- DOI
10.1530/EJE-22-0751